Gritstone bio Stock Price, News & Analysis
Company Description
Gritstone bio (NASDAQ: GRTS) is a publicly traded biological product (except diagnostic) manufacturing company in the Biological Products, (no Disgnostic Substances) sector. The company has a market capitalization of $3.8M, ranking #6,811 among all listed U.S. companies by market cap.
GRTS stock has declined 98.3% over the past year. Shares last traded at $0.0322.
This page provides a comprehensive overview of GRTS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Gritstone bio (GRTS) stock last traded at $0.0322. Over the past 12 months, the stock has lost 98.3%. At a market capitalization of $3.8M, GRTS is classified as a micro-cap stock with approximately 118.1M shares outstanding.
Latest News
Gritstone bio has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, conferences, covid-19. View all GRTS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GRTS Company Profile & Sector Positioning
Gritstone bio (GRTS) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.